ConductScience.org, home

Paper2536282

Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease.

Freedman RR and 4 others. Arthritis Rheum, 1989. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease. Papers, record 2536282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2536282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease.
PubMed
Journal
Arthritis Rheum
PubMed
Year
1989
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
2.69
iCite
Revised in PubMed
2019-07-18
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Freedman RRR R
2Sabharal SCS C
3Desai NN
4Wenig PP
5Mayes MM

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FingersMajor topic
Raynaud DiseaseMajor topic
Receptors, Adrenergic, alphaMajor topic
Adult
Aged
Blood Flow Velocity
Blood Pressure
Clonidine
Cold Temperature
Female
Hot Temperature
Humans
Infusions, Intra-Arterial
Isoproterenol
Male
Middle Aged
Phenylephrine
Receptors, Adrenergic, beta
Tyramine

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HL-30604NHLBI NIH HHSUnited StatesR01HL030604PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
37828025ADRA2A and IRX1 are putative risk genes for Raynaud's phenomenon.Nat Commun2023https://conductscience.org/library/papers/37828025PubMed
36082186Digital ischemia after lidocaine with epinephrine injection in a patient with primary Raynaud's phenomena.Case Reports Plast Surg Hand Surg2022https://conductscience.org/library/papers/36082186PubMed
25536485A vascular mechanistic approach to understanding Raynaud phenomenon.Nat Rev Rheumatol2015https://conductscience.org/library/papers/25536485PubMed
23056098The correlation between blood pressure and hot flashes in menopausal women.ARYA Atheroscler2012https://conductscience.org/library/papers/23056098PubMed
9118818Pharmacotherapy of Raynaud's phenomenon.Drugs1996https://conductscience.org/library/papers/9118818PubMed
8323396Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.Ann Rheum Dis1993https://conductscience.org/library/papers/8323396PubMed
2148371Dermatology.Postgrad Med J1990https://conductscience.org/library/papers/2148371PubMed
1854864Physiological mechanisms of temperature biofeedback.Biofeedback Self Regul1991https://conductscience.org/library/papers/1854864PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2536282

GET https://conductscience.org/api/papers/v1/2536282/authors